Objective
We assessed whether maternal C-reactive protein (CRP) levels during pregnancy and CRP gene variations are associated with wheezing and lower respiratory tract infections (LRTIs) in offspring.
Study Design
Information on wheezing and LRTIs in the offspring at 6 and 14 months of age, and maternal CRP levels and genotype was obtained from a population-based birth cohort.
Results
A total of 63 children (12.5%) experienced recurrent wheezing and 61 (12.4%) a recurrent diagnosis of LRTIs. Children in the highest tertile of maternal CRP levels had a higher risk of experiencing recurrent wheezing (adjusted odds ratio, 2.87; 95% confidence interval, 1.23–6.71) and being diagnosed with recurrent LRTIs (odds ratio, 2.37; 95% confidence interval, 1.01–5.55), as compared with children in the lowest tertile. The rs1205 polymorphism influenced maternal serum CRP levels but not the risk of the offspring outcomes.
Conclusion
Higher CRP levels in pregnancy are associated with wheezing and LRTIs in offspring. However, genetic variation in CRP influencing maternal levels is not related to these phenotypes.
C-reactive protein (CRP) is a key acute phase protein widely used as a sensitive biomarker of systemic inflammation. In addition to response to stress, acute infections, tissue injury, and other inflammatory processes, there is a well-established relationship between elevations in serum CRP concentration and advancing age, obesity, smoking, lack of physical activity, low socioeconomic status, race, and ethnicity. Recently systemic inflammation measured by CRP serum levels has been associated with impaired lung function, asthma, asthma symptoms, and chronic obstructive pulmonary disease.
An elevated inflammatory response in pregnant women measured by serum CRP levels has been related to adverse pregnancy outcomes including preeclampsia, preterm delivery, and intrauterine growth restriction. Recent research has started to focus on the possible role of the antenatal environment as an important factor in the development of the fetal immune system and in the subsequent occurrence of allergic and respiratory diseases, including atopy and asthma. Maternal exposures during pregnancy, such as cigarette smoking, have been associated with the offspring’s lung function and predisposition to wheezing in the first years of life. As yet, potential biomarkers, pathways, and mediators of an increased vulnerability of offspring to develop allergic and respiratory diseases in response to intrauterine conditions remain unknown.
CRP serum levels are partly under genetic control, and several single nucleotide polymorphisms (SNPs) in the CRP gene have been shown to be associated with differences in baseline CRP levels in humans. Genetic variants that are specifically associated with variation in plasma levels of CRP provide an ideal instrument to assess whether lifelong CRP levels lead to phenotype expression, independently of other risk factors, and to evaluate the risk of reverse causality (ie, the risk that the disease process is causing the increase in CRP levels, rather than the opposite). In Mendelian randomization design because alleles are randomly distributed during gamete formation genetic variants that influence an intermediate phenotype, such as the levels of biomarkers, provide an unbiased method for assessment of the possibly causal nature of observed associations between the biomarker and disease.
We aimed to assess whether maternal CRP serum levels in pregnancy and maternal common variation in the CRP gene are associated with the risk of developing wheezing and lower respiratory tract infections (LRTIs) in the offspring at early age.
Materials and Methods
Study population
Data come from a population-based birth cohort established in the city of Sabadell (Catalonia, Spain) as part of the Infancia y Medio Ambiente (INMA) Environment and Childhood Project. Between July 2004 and July 2006, 657 pregnant women who visited the public primary care center of Sabadell for an ultrasound in the first trimester of pregnancy were recruited. A total of 99.5% of Spaniards have public health insurance, and an estimated 70-90% of women use public health services during pregnancy.
The participation rate was 60% (657/1097 eligible women). The educational achievement of women who refused to participate was lower than that of participants (58% had secondary education or less, compared with 28% in participants), although no differences in age were found. Among the participants, 504 mothers who had CRP levels measured in serum during pregnancy and provided complete outcome data on their children up to their 14th month visit (76.7%) were included in the present analysis.
Information on education, social class (using the International Standard Classification of Occupations [ISCO-88] code), demographic factors, marital status, maternal disease and obstetric history, parity, alcohol consumption and smoking habits during pregnancy, and physical activity was obtained by questionnaires administered by trained interviewers at recruitment, during the third trimester and at delivery. Gestational age and anthropometric measures were collected from clinical records. Informed consent was obtained from all participants, and the study was approved by the Clinical Research Ethical Committee of the Municipal Institute of Health Care, Barcelona.
Offspring wheezing and LRTIs
Information about the presence of respiratory symptoms and physician-confirmed diagnosis of LRTIs was obtained from parents through questionnaires completed when the child was 6 and 14 months old. At 6 months parents were asked whether the infants had ever experienced “whistling or wheezing from the chest but not noisy breathing from the nose” since birth. Subsequently when children were 14 months old, parents were asked whether the infants had ever experienced “whistling or wheezing from the chest but not noisy breathing from the nose” since the last interview.
Children were classified as “never wheezing” (no episodes of wheezing during first 14 months of life), “infrequent wheezing” (any episode of wheeze either during the first 6 months or from 6 to 14 months) and “recurrent wheezing” (episodes of wheeze both at 6 and at 14 months of age). Occurrence of an LRTI was defined as a positive answer to the question, “Has a doctor ever told you that your son/daughter has had a chest infection?” A second question referred specifically to a doctor diagnosis of either bronchitis, bronchiolitis, or pneumonia. Agreement between the 2 questions was almost perfect.
Similarly, children were classified as “never LTRI” (never diagnosed with having a chest infection), “infrequent LRTI” (diagnosed by a doctor with chest infections either during the first 6 months or from 6 to 14 months) and “recurrent LRTI” (diagnosed by a doctor with a chest infection both at 6 and at 14 months of age).
CRP level measurement and CRP genotyping
Maternal blood was collected at recruitment (mean ± SD, 13.4 ± 1.7 weeks of gestation). Serum CRP values were determined by turbidimetric assay using a Hitachi modular analyzer system (Roche Modular DPP, Hitachi Ltd, Tokyo, Japan) at the Laboratori de Referencia de Catalunya. The minimum detectable concentration of CRP was 0.2 mg/dL. For participants who had a CRP value below the detection limit (15.9%), we imputed a value of half of the detection limit.
SNP rs1205 (2042C>T) was selected based on its known association with CRP plasma levels. CRP genotyping deoxyribonuclease (DNA) extraction from maternal total blood was performed at the Spanish National Genotyping Centre using the Chemagic Magnetic Separator technology (Chemagen). DNA samples were quantified using PicoGreen double-stranded DNA fluorescent detection (Molecular Probes, Eugene, OR) and normalized to the same concentration. The rs1205 variant was genotyped by TaqMan allelic discrimination (C_7479334-10; Applied Biosystems, Foster City, CA) following the manufacturer’s instructions. Replicate quality and positive controls were included and genotyped with 100% concordance. The rs1205 genotypes were in Hardy-Weinberg equilibrium both in the total analyzed cohort and among 412 mothers of European white descendent.
Statistical analysis
Accepting an alpha risk of 0.05 in a 2-sided test with 307 subjects in the control group (never diagnosed of LRTI) and 61 children reporting recurrent diagnosis of LRTI, the statistical power was 0.82 to recognize as statistically significant the difference in proportions from 0.27 in the control group (proportion of children never diagnosed of LRTI in the highest tertile of CRP) to 0.47 (proportion of children diagnosed of recurrent LRTI in the highest tertile of CRP).
Statistical analyses were performed with the Stata 8.0 statistical software (StataCorp, College Station, TX). Because maternal CRP serum concentrations were not normally distributed, we used a natural logarithmic transformed variable and geometric mean with 95% confidence intervals are reported. In addition, maternal serum CRP concentrations were categorized into tertiles to assess dose-response relation with offspring outcomes studied. Multinomial logistic regression analysis was conducted to model the adjusted association between maternal CRP concentrations during pregnancy and the development of wheezing and LRTIs in offspring at early age.
All variables significantly related with wheezing or LRTIs in the bivariate models ( P < .2) were included in the multivariate model and retained only if they had an at least marginally significant association ( P < .1) or modified the coefficient of maternal CRP levels by at least 5%.
Final multivariate models were adjusted for sex, birthweight, prematurity, small for gestational age, maternal smoking during pregnancy (number of cigarettes per day), parity as an indicator of having elder siblings at home (0, 1, ≥1), maternal body mass index before pregnancy (kilograms per square meter) (<20, 20-24.99, 25-29.99, ≥30), maternal total immunoglobulin (Ig) E (log transformed), maternal alcohol consumption in pregnancy (no, yes), day care attendance (no, yes), breast-feeding duration (never, 0-16 weeks, 14-24 weeks, and more than 24 weeks), and maternal dichlorodiphenyldichloroethylene serum levels in pregnancy (log transformed).
Allowance for other possible confounding variables (eg, maternal age, maternal social class, maternal education level, and maternal physical activity) did not change effect estimates and were therefore not included in the regression model. Significance was accepted at P < .05.
Results
During their first 14 months of life, 323 children (64.1%) never wheezed, 181 (35.9%) experienced wheezing episodes, and 63 of these (12.5%) experienced recurrent wheezing. Overall, 197 (38.2%) of the children were diagnosed with LRTIs by age of 14 months, and 61 of these (12.4%) were diagnosed with recurrent LRTIs ( Table 1 ). As expected, wheezing and diagnosis of LRTIs during the first 14 months of life were highly correlated.
Wheezing | |||||
---|---|---|---|---|---|
Variable | Total | Never | Infrequent | Recurrent | P value a |
LRTIs | |||||
Never | 307 (61.0) | 266 (82.4) | 36 (30.5) | 5 (7.9) | < .001 |
Infrequent | 136 (26.8) | 51 (15.7) | 66 (55.9) | 19 (30.2) | |
Recurrent | 61 (12.4) | 6 (1.9) | 16 (13.6) | 39 (61.9) | |
Total | 504 (100.0) | 324 (64.1) | 118 (23.4) | 63 (12.5) |
Recurrent wheezing was associated with being male ( P = .035), having elder siblings ( P < .001), and having mothers who were obese before pregnancy ( P = .039), or smoked during pregnancy ( P = .048). Also, mothers of children with recurrent wheezing showed higher serum levels of total IgE ( P = .023). Recurrent LRTI was associated with the presence of elder siblings ( P < .001), maternal age ( P < .001), and maternal serum levels of total IgE ( P = .032).
Median concentration of maternal CRP was 4.0 mg/L (interquartile range, 2.0–7.0). Higher CRP concentrations were found among mothers of children who experienced infrequent and recurrent wheezing in comparison with mothers of children who never wheezed ( P for trend < .001) ( Table 2 ). Similarly, mothers of children diagnosed with infrequent and recurrent LRTIs had higher CRP levels than mothers of children never diagnosed with LRTI ( P for trend < .001). Interestingly, none of the maternal allergic outcomes assessed was significantly related to higher serum CRP levels in pregnancy ( Table 2 ).